Objective: The aim of this study was to investigate whether minor abnormalities of glucose metabolism without gestational diabetes are a risk factor for fetal overgrowth. Design: A sample of 1883 unselected white mother-infant pairs were screened for gestational diabetes using a 50 g 1-h oral glucose challenge test (GCT) in two periods of pregnancy: early (16-20 weeks) and late (26-30 weeks). Methods: The effects of risk factors (glucose metabolism, previous history of mothers, obesity, multiparity and age of mothers) were estimated using a multinomial logit model. Results: The level of risk was related to gestational age at the appearance of an abnormal GCT. Patients with an abnormal GCT in the early and late periods of pregnancy (Group 1) had a risk of delivering a large for gestational age (LGA) infant seven times higher than the control group (normal GCT in both periods), and patients with a normal GCT in the early period and an abnormal GCT in the late period (Group 2) showed a risk three times higher than the control group. Among the historical risk factors for LGA infants, such as maternal obesity, multiparity, previous gestational diabetes and previous delivery of an infant weighing 4000 g or more, only the latter was associated with fetal overgrowth with a risk level 4.7 higher than the control group. Group 1 patients had a significantly higher incidence of pregnancy-induced hypertension and preterm birth. There were no differences in the frequency of 5-min Apgar score <7 and metabolic complications among the infants of all groups. We found a significantly higher rate of shoulder dystocia in Group 1 infants than in infants in the other groups. Conclusions: Our results suggest that a positive GCT at 26-30 weeks is the most important risk factor for fetal overgrowth. This result was strongly enforced in patients who had also shown a positive early GCT at 16-20 weeks.
Introduction
Maternal diabetes is only one of the factors associated with fetal overgrowth; most large for gestational age (LGA) infants are born to non-diabetic mothers. Several other conditions frequently associated with fetal overgrowth are maternal obesity, multiparity and previous delivery of an infant heavier than 4000 g (1) . A positive relationship has been found between maternal prepregnancy weight and neonatal weight-height index, in both diabetic and control subjects (2) .
There is an increased incidence of LGA infants, not only in pregnant women who equal or exceed the threshold values defining gestational diabetes (GDM) on an oral glucose tolerance test (OGTT), but also among women exhibiting lower degrees of glucose intolerance (3) . A previous study (4) showed that patients who had elevated 1-h glucose screening test values and normal OGTT results delivered macrosomic neonates significantly more often than those with normal glucose screening results. Another report (5) showed a positive association between 1-h glucose screening test values and birth weight. Women who had only one elevated value on an OGTT had macrosomic neonates significantly more often than those having normal glucose screens (6) and normal OGTT (7, 8) . These findings support the concept of a continuum of glucose abnormality and the thesis that an abnormal glucose challenge test (GCT) in pregnancy is a risk factor for LGA.
The purpose of the present investigation was to examine first the influence of factors such as maternal obesity, multiparity, previous GDM, previous delivery of an infant weighing 4000 g or more and GCT results on fetal growth, and secondly to evaluate the effect of a positive GCT in the absence of GDM, both on the incidence of obstetrical complications (pregnancyinduced hypertension, intrauterine growth retardation, polyhydramnios, preterm births) and mode of delivery, and on neonatal complications (Apgar score, metabolic complications, respiratory distress syndrome, shoulder dystocia).
Materials and methods
Universal screening for GDM with the 1-h GCT is used in the antenatal unit of the Institute of Obstetrics and Gynecology of the University of Florence.
The present investigation involved 1883 white mother-infant pairs screened between September 1989 and December 1992. The study received ethical approval and all the subjects gave their informed consent. Women were screened in two periods of pregnancy: early (16-20 weeks) and late (26-30 weeks). The screening test consisted of a 50 g oral glucose load followed by plasma determination 1 h later. If the plasma glucose level was 7.5 mmol/l or greater, a 3-h OGTT was performed within 1 week. After the fasting plasma sample was withdrawn, a 100 g oral glucose load was given and plasma samples were collected after 1, 2 and 3 h. Interpretation of OGTT results was made in accordance with the criteria established by Carpenter & Coustan (9) . Anyone with an early negative GCT or an early positive GCT followed by a negative OGTT underwent a second screening test in the later period of pregnancy. All glucose determinations were conducted using the glucose oxidase method.
By using a threshold of 7.5 mmol/l, we hoped to identify almost all the cases of GDM whilst avoiding the performance of a 3-h OGTT in most of our patients. Carpenter & Coustan (9) found that the screening test sensitivity at this threshold is closer to unity, that is, the proportion of gravid women with GDM missed by the screening test is reduced to nearly zero. O'Sullivan et al. (10) reported the prevalence of GDM among pregnant women with screening test (plasma) values below 7.9 mmol/l to be 0.7%. It is reasonable to assume that the prevalence is substantially smaller below 7.5 mmol/l. There may be uncommon occasions of patients with a test value below 7.5 mmol/l and an abnormal glucose tolerance test.
In our population, the incidence of GDM was 4.4% (83 of 1883) in the early period and 7.6% (137 of 1800) in the late period. The overall incidence was therefore 11.7% (220 of 1883).
In order to investigate the effect of abnormalities of glucose metabolism on fetal overgrowth, we used GCT and OGTT results to classify women into seven groups, each representing a different pattern of glucose metabolism. Group 1: patients with abnormal GCT but absence of GDM in both periods of pregnancy. Group 2: patients with normal GCT in the early period and abnormal GCT but absence of GDM in the late period.
Group 3: patients with abnormal GCT but absence of GDM in the early period and normal GCT in the late period. Group 4: patients with normal GCT in both periods. Group 5: patients with GDM in the early period. Group 6: patients with normal GCT in the early period and GDM in the late period. Group 7: patients with abnormal GCT but normal OGTT in the early period and GDM in the late period.
Patients with GDM (Groups 5, 6 and 7) received their antenatal care and delivered at the Institute of Obstetrics and Gynecology of the University of Florence. All patients were taught self-monitoring of blood glucose levels with a memory-based reflectance. Study participants performed a 24-h glycemic profile, consisting of one measurement every 2 h, twice a week. Insulin therapy was introduced in patients with a fasting capillary glucose level greater than 5.3 mmol/l or postprandial capillary glucose levels greater than 6.7 mmol/l. Patients were asked to return to the metabolic study unit at 2-week intervals to have adjustments made to their insulin therapy or diet mode to optimize control.
Plasma glucose values during OGTT, both in early and in late pregnancy, in each of the seven groups are presented in Table 1 .
Several characteristics were collected at the time of the first screening for each patient: these consisted of a sociodemographic profile and a summary of past obstetric and medical data, including traditional risk factors associated with GDM and fetal overgrowth. The previous history of the mothers identified three groups of patients: (a) patients with previous GDM; (b) patients with previous delivery of an infant weighing 4000 g or more, but in the absence of previous GDM; and (c) patients with neither previous GDM nor previous delivery of an infant weighing 4000 g or more. Obesity was defined as prepregnancy body mass index (BMI) greater than 25.0 kg/m 2 (11) . Multiparity was defined as a parity greater than two. Gestational age was assigned by the last menstrual period with confirmation by first trimester ultrasound. In cases of late prenatal care, we used ultrasound to assign gestational age. In our study no patient was allowed to progress beyond 42 weeks of gestation. Infants were considered to be appropriate for gestational age (AGA) when their birth weight ranged between the 90th and the 10th percentile, LGA when their birth weight was equal to or greater than the 90th percentile and small for gestational age (SGA) when their birth weight was equal to or less than the 10th percentile on the basis of growth standards developed for our population (12) . Some descriptive statistics of maternal characteristics and neonatal outcomes are reported in Table 2 .
In order to meet the second aim of the analysis, pregnancies were considered to be complicated in the presence of pregnancy-induced hypertension, intrauterine growth retardation, polyhydramnios and preterm delivery. Criteria for the diagnosis of pregnancy-induced hypertension were based on the classification of Davey & MacGillivray (13) . Diagnosis of intrauterine growth retardation was based on a pathologic decrease in the rate of fetal growth (14) . Polyhydramnios was defined as an amniotic fluid index greater than the 95th percentile for gestational age (15) . Any delivery occurring before 37 completed weeks from the first day of the last menstrual period was considered to be a preterm birth (16) .
Neonatal complications considered in the study were: 5-min Apgar score <7, hyperbilirubinemia, hypocalcemia, hypoglycemia, respiratory distress syndrome, shoulder dystocia. Hypoglycemia (capillary heel blood) was diagnosed if any two consecutive values of plasma glucose were less than 1.7 mmol/l. Hyperbilirubinemia was characterized by plasma values equal to or greater than 204 mmol/l. Hypocalcemia (equal to or less than 1.7 mmol/l) was assessed when clinically indicated (jitters, tremors, etc.). The diagnosis of respiratory distress syndrome was based on clinical signs, blood gas values, need for respiratory assistance, and X-ray findings typical of this syndrome. None of the newborns were born from multiple pregnancies or had congenital anomalies and there were no macrosomic newborns (birth weight greater than 4000 g) associated with post-date (more than 42 weeks) pregnancies.
Statistical analysis
The first aim of the analysis was to assess the effects of the risk factors on the distribution of infants among the three fetal growth categories (AGA, LGA, SGA). Since the response variable is classified on three nominal levels we used a multinomial logit model to evaluate the influence of the risk factors on fetal overgrowth (17) . The risk factors involved in the specification of the model were glucose metabolism (seven different patterns identified by the previous classification), previous history of the mothers, obesity, multiparity and mothers older than 35 years.
In our specification of the model the reference category of the response variable was the AGA class. Therefore the influence of risk factor levels on fetal overgrowth can be read through two parameters: one contrasting LGA with AGA infants, the other SGA with AGA infants. The parameter associated with a level of a risk factor can be interpreted as the logarithm of the odds ratio between that level and the reference category. The odds are the probability of being LGA (or SGA) over the probability of being AGA, given the level of the risk factor. Therefore, the risk of fetal overgrowth can be measured by the exponential of the parameter value. An odds ratio greater than 1 indicates a higher relative frequency of LGA (or SGA) for the corresponding risk factor level with respect to the reference category.
The model selection (i.e. the choice of significant factors) was based on the likelihood ratio test; confidence intervals for each odds ratio were constructed using the normal approximation. Single odds ratios are considered statistically significant if the correspondent 95% confidence interval does not cover unity. The application was conducted using the GLIM package (18) .
In order to evaluate the effect of a positive GCT in the absence of GDM on maternal (pregnancy-induced hypertension, intrauterine growth retardation, polyhydramnios, preterm birth, operative delivery) and neonatal (Apgar score, metabolic complications, respiratory distress syndrome, shoulder dystocia) outcomes, attention was focused on the first four groups previously defined on the basis of GCT and OGTT results. Differences in incidence of maternal and neonatal complications among groups were evaluated with x 2 analysis and Fisher's exact tests. Statistical significance was defined as P<0.05. Table 3 shows the odds ratios and the 95% confidence intervals for each level of the factors considered.
Results
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Fetal macrosomia and testing 29 Different patterns of glucose metabolism and the previous history of mothers showed a significant influence on birth weight, while multiparity, obesity and age of mothers seemed not to be significant factors.
The interactions between all the considered factors were not statistically significant and are not reported in Table 3 . Patients belonging to Groups 1, 2 and 6 showed a significant increase in the risk of fetal overgrowth (LGA) with respect to patients with normal glucose metabolism (reference category). The highest level of risk was achieved by patients in Group 1: the estimated odds ratio indicated a risk seven times higher than in the control group. This high level was not due to the higher incidence of previous GDM and the higher maternal age of patients in Group 1 (see Table 2 ), since the parameters measuring the interaction between glucose metabolism and previous history and age of mothers were not significant. Patients with previous delivery of an infant of 4000 g or more showed a risk 4.7 times greater than patients having a normal history. In our analysis, the absence of interactions between glucose metabolism and the previous history of the mothers indicated that the risk due to previous delivery of an infant of 4000 g or more does not significantly differ among groups.
Obstetrical complications, mode of delivery and neonatal complications of Groups 1, 2, 3 and 4 (control group) are shown in Table 4 . Patients of Group 1 had a significantly higher incidence of pregnancy-induced hypertension. Comparable rates of intrauterine growth retardation and polyhydramnios were found between the four groups. A significantly higher rate of preterm births was found in Group 1 compared with Group 3 and the control group. There was no significant difference in the frequency of normal spontaneous delivery, Cesarean section and vacuum extraction.
There was no difference in the frequency of 5-min Apgar scores <7. Comparison of metabolic complications, such as hyperbilirubinemia, hypocalcemia and hypoglycemia revealed no significant differences among the four groups. No significant difference was found also in the incidence of respiratory distress syndrome. There was a significantly higher risk for shoulder dystocia for the infants of Group 1 compared with those of the control group.
Discussion
The results of this study are consistent with previous reports that minor abnormalities of glucose metabolism without GDM are a significant risk factor for fetal overgrowth (3, 4, (6) (7) (8) 19) . The level of risk is related to gestational age at the onset of abnormal maternal glucose metabolism. Patients with abnormal GCT in the early and late periods of pregnancy (Group 1) had a risk of LGA infants seven times higher than the control Table 2 Maternal and neonatal characteristics. group and patients with normal GCT in the early period and abnormal GCT in the late period (Group 2) showed a risk three times greater than the control group. The patients of Group 3 did not differ significantly from the control group. Our results suggest that a positive GCT at 26-30 weeks is the most important risk factor for fetal overgrowth. This result is strongly enforced in patients who also have a positive early GCT at 16-20 weeks. The current study supports the consideration of a positive 1-h glucose screen itself as a marker of abnormal carbohydrate metabolism with effects on fetal growth. Leikin et al. (4) showed that minor carbohydrate intolerance in subjects with an elevated EUROPEAN 
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Fetal macrosomia and testing 31 (20) have also found that patients with abnormal 50 g screen values but normal OGTT had significantly higher insulin output and insulin-glucose ratios than those with normal GCT. Landy et al. (21) have shown that a glucose screen above 10·3 mmol/l is associated with a probable diagnosis of GDM and predictive of neonatal macrosomia and hypoglycemia in their patient population and suggested the use of this approach in the diagnosis of GDM without using the 3-h OGTT. Both mothers with GDM in the early period (Group 5) and those with an abnormal GCT but a normal OGTT in the early period and GDM in the late period (Group 7) showed rates of LGA infants not significantly higher than the control group; this may occur because of the higher proportion of women treated with insulin in Group 5 and Group 7 (71·1% and 61·4% respectively). In contrast, mothers with normal GCT in the early period and GDM in the late period (Group 6) showed a risk 2·1 times greater than the control group probably because of the lower proportion (16·3%) of women treated with insulin. These findings, as well as those from other studies (22, 23) , suggest that insulin therapy may have contributed to the prevention of fetal overgrowth in our subjects, lowering the rate of LGA infants independently of the period of the onset of abnormal maternal glucose metabolism (23) .
Among the historical risk factors for LGA infants such as multiparity, obesity, previous GDM and previous delivery of an infant weighing 4000 g or more, only the latter was associated with fetal overgrowth when controlling for glucose metabolism, with a level of risk 4·7 times greater than the reference group. The high frequency of increased birth weights in subsequent pregnancies is well accepted. Bakketeig et al. (24) found that the incidence of an LGA infant was 47·9% in the second birth if the first was LGA, compared with 18·8% if the first birth was AGA.
Our finding of an increased risk of pregnancy-induced hypertension in Group 1 is consistent with the findings of Lindsay et al. (6) who observed a significant increase in the incidence of this complication in women with minor degrees of maternal glucose intolerance.
Cesarean delivery rates were similar in Group 1 and the control group despite very different LGA rates between the two groups. This may be because of our policy of performing elective Cesarean section for all infants with an estimated weight greater than or equal to 4250 g: among the 70 LGA infants of Group 1, only 6 (8·6%) (data not shown) had a birth weight above this threshold.
A threefold higher rate of shoulder dystocia was found in Group 1 compared with the other two groups. This fact may be related to the higher incidence of LGA infants in this group.
